ReviewCardiovascular and interventional radiology2026
Virtual Reality as an Anxiolytic and Analgesic in Interventional Radiology Procedures: An Evidence-Based Review and Practical Framework.
Review in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the clinical efficacy, mechanisms, and feasibility of immersive virtual reality (VR) as a non-pharmacological anxiolytic and analgesic in interventional radiology (IR).
methodsA literature search for a narrative review was conducted on June 7, 2026, across MEDLINE, EMBASE, and Web of Science. Prospective pilot studies and randomized controlled trials that evaluated VR as an intraprocedural anxiolytic or analgesic modality during percutaneous or endovascular interventions were included.
resultsAnalysis of 9 clinical trials demonstrated substantial reductions in procedural distress. In a randomized controlled trial involving 120 patients undergoing peripheral arterial angioplasty, VR was associated with significant improvements in patient-reported intraprocedural pain (visual analog scale: 6.23 ± 0.91 vs. 8.03 ± 0.94; p < 0.001) and anxiety (State-Trait Anxiety Inventory-6-Item: 47.60 ± 7.42 vs. 67.97 ± 9.95; p < 0.001). Furthermore, combining VR with guided breathing during percutaneous transhepatic biliary drainage reduces post-procedural opioid consumption (20.25 vs. 56.61 morphine milligram equivalents, p = 0.044).
conclusionsVR is an effective, sedation-sparing digital tool for short, simple IR procedures. Application in complex, long endovascular cases remains investigational.
Indexed as
Identifiers
42618657What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.